TIDES Europe: Oligonucleotide and Peptide Therapeutics is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Jens Bukrinski
Head of R&D at SB3000 Ltd.

Profile

Jens has 20+ years’ experience in the pharmaceutical development from academia, Novo Nordisk and Novozymes Biopharma R&D and as an independent advisor. Having been involved in more than 25 drug development projects & with 5 drugs currently on the market Jens has substantial experience in drug development spanning from early stage R&D through clinical development, BLA and MAA submission and life cycle management. Jens holds a MSc in Dairy Science and technology and a PhD in structural biology. After eight years in academia as post doc at University of Copenhagen and research associate professor at Carlsberg laboratory studying structure and function of proteins he moved into drug development industry. In 2016 he founded CMC assist providing independent counseling to pharma, biotech and related industries within CMC development including regulatory strategy and documentation.

Jens Bukrinski's Network

Agenda Sessions

  • Ultra-fast Development and Optimization of Large-Scale Peptide Manufacturing Processes

    , 15:00